Investor Relations

News Releases

 
News Releases
  Date Title View
Nov 23, 2010
BEDFORD, Mass., Nov 23, 2010 (BUSINESS WIRE) --Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that Kevin Quinlan, chief financial officer, will be presenting at the New York Society of Security Analysts (NYSSA) Biotech and Specialty Pharmaceuticals Conference on Tuesday, November 30, 2010. A live audio ...
Nov 8, 2010
BEDFORD, Mass., Nov 08, 2010 (BUSINESS WIRE) --Anika Therapeutics, Inc. (Nasdaq: ANIK) today anno...
Nov 8, 2010
BEDFORD, Mass., Nov 08, 2010 (BUSINESS WIRE) --Anika Therapeutics, Inc....
Oct 21, 2010
BEDFORD, Mass., Oct 21, 2010 (BUSINESS WIRE) --Anika Therapeutics, Inc. (Nasdaq: ANIK) today anno...
Sep 9, 2010
BEDFORD, Mass., Sep 09, 2010 (BUSINESS WIRE) --Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced that Charles Sherwood, president and chief executive officer, will be presenting at the Rodman & Renshaw Annual Global Investment Conference on Wednesday, September 15, 2010 at 9:10 a.m. ET. A live audio webcas...
Aug 9, 2010
BEDFORD, Mass., Aug 09, 2010 (BUSINESS WIRE) -- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid ("HA") technology, today reported financial results for the quarter ended June 30, 2010. Key Highlights ...
Jul 13, 2010
BEDFORD, Mass., Jul 13, 2010 (BUSINESS WIRE) -- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced ...
Jul 12, 2010
BEDFORD, Mass., Jul 12, 2010 (BUSINESS WIRE) --Anika Therapeutics, Inc. (Nasdaq: ANIK), ...
May 13, 2010
BEDFORD, Mass., May 13, 2010 (BUSINESS WIRE) --Anika Therapeutics, Inc. (Nasdaq: ANIK) announced today that the U.S. Food and Drug Administration (FDA) has accepted the corrective actions put forth by Anika to address the issues raised in the 2008 Warning Letter received by the company, and therefore has removed any restrictions placed upon Anik...
May 10, 2010
BEDFORD, Mass., May 10, 2010 (BUSINESS WIRE) --Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid ("HA") technology, today reported financial results for the quarter ended March 31, 2010. Key Highlights ...

= add release to Briefcase